# Reveal Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reveal-biosciences

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.revealbio.com
- Latest round: Series A (Apr 1, 2019)
- Investors on record: 3

## About

Founded in 2012 and based in California, US, Reveal Biosciences, Inc. is a computational pathology company focused on tissue-based research that combines traditional histopathology and artificial intelligence to deliver actionable data. The company was founded by its CEO Claire Weston and CTO Casey Laris. In April 2019, Reveal Biosciences, Inc. raised an undisclosed amount of Series A funding led by new investor Intel Capital, with participation from other new investors GNI Ltd. and PP Capital. As of 2019, the company has around 25 employees.

Reveal Biosciences combines artificial intelligence with pathology to diagnose disease from large whole-slide microscope images. The company’s proprietary deep-learning platform, ImageDx™, provides pathologists and scientists a novel class of actionable, quantitative data from their whole-slide pathology images by increasing its accuracy, reproducibility, and scale to advance their research and enhance patient care. The company's services include computational diagnostics, companion diagnostics, clinical trials, patient stratification, disease diagnosis, tumor detection, and automated NASH. The company also provides biopharma assay services such as advanced tissue processing, staining, and analysis. 

Reveal Biosciences plans to expand its ImageDx™ online software platform with a pipeline of AI-based decision support tools.

## Funding rounds

- Series A, Apr 1, 2019 — Intel Capital, GNI Ltd., PP Capital

## Investors

- Intel Capital (https://capitalatlas.ai/funds/intel-capital) — Series A
- GNI Ltd. — Series A
- PP Capital (https://capitalatlas.ai/funds/pp-capital) — Series A